Grants per year
Personal profile
Research Interests
Pathogenesis & treatment of pituitary tumors, treatment of diabetic complications
Certifications and Licenses
| Internal Medicine | |
| Endocrinology, Diabetes & Metabolism |
Training Experience
| 1972 | Residency, Hospital of the University of Pennsylvania |
| 1975 | Fellowship, Univ. of CA-Los Angeles Med. Ctr. |
Expertise related to UN Sustainable Development Goals
In 2015, UN member states agreed to 17 global Sustainable Development Goals (SDGs) to end poverty, protect the planet and ensure prosperity for all. This person’s work contributes towards the following SDG(s):
Education/Academic qualification
MD, University of Pennsylvania
… → 1969
Research interests
- Diabetes
- Endocrinology
- Medicine
- Metabolism
Fingerprint
Dive into the research topics where Mark E Molitch is active. These topic labels come from the works of this person. Together they form a unique fingerprint.
- 1 Similar Profiles
Network
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Prot#CLCI699C2X01B: An Open-label, Multi-Center, Roll-Over Study to Assess Long Term Safety in Patients with Endogenous Cushing’s Syndrome Who Have Completed a Prior Novartis-Sponsored Osilodrostat (LCI699) Study and are Judged by the Investigator to Bene
Novartis Pharmaceuticals Corporation
5/22/19 → 12/31/24
Project: Research project
-
Improve PAD PERformance with METformin. The PERMET Trial
McDermott, M. M., Lloyd-Jones, D. M., Molitch, M. E., Sufit, R. L. & Zhao, L.
National Heart, Lung, and Blood Institute
12/9/16 → 11/30/22
Project: Research project
-
Prot#CRN00808-02: A Double-blind, Placebo-controlled, Randomized Withdrawal Study to Evaluate the Safety, Pharmacokinetics and Efficacy of CRN00808 in Patients with Acromegaly that are Responders to Octreotide Lar or Landreotide (ACROBAT EVOLVE)
Accelsiors CRO and Consultancy Services Ltd., Crinetics Pharmaceuticals, Inc.
8/6/19 → 8/6/22
Project: Research project
-
Prot#CRN00808-03: An Open Label Exploratory Study to Evaluate the Safety, Pharmacokinetics and Efficacy of CRN00808 in Patients with Acromegaly Treated with Somatostatin Analogue Based Treatment Regimens (ACROBAT EDGE)
Accelsiors CRO and Consultancy Services Ltd., Crinetics Pharmaceuticals, Inc.
8/6/19 → 8/6/22
Project: Research project
-
Early Trajectory of Estimated Glomerular Filtration Rate and Long-term Advanced Kidney and Cardiovascular Complications in Type 1 Diabetes
Perkins, B. A., Bebu, I., Gao, X., Karger, A. B., Hirsch, I. B., Karanchi, H., Molitch, M. E., Zinman, B., Lachin, J. M. & de Boer, I. H., Mar 1 2022, In: Diabetes care. 45, 3, p. 585-593 9 p.Research output: Contribution to journal › Article › peer-review
-
Exercise based assessment of cardiac autonomic function in type 1 versus type 2 diabetes mellitus
Goldberger, J. J., Pelchovitz, D. J., Ng, J., Subacius, H., Chicos, A. B., Banthia, S., Molitch, M. & Goldberg, R. B., Apr 7 2022, In: Cardiology Journal. 29, 2, p. 272-283 12 p.Research output: Contribution to journal › Article › peer-review
Open Access -
Glucocorticoid receptor blockers
Molitch, M. E., 2022, (Accepted/In press) In: Pituitary.Research output: Contribution to journal › Review article › peer-review
1 Scopus citations -
Hyperglycaemia management in non-critical care settings: guidelines in focus
Molitch, M. E., Sep 2022, In: The Lancet Diabetes and Endocrinology. 10, 9, p. 614-616 3 p.Research output: Contribution to journal › Comment/debate › peer-review
-
KDOQI US Commentary on the KDIGO 2020 Clinical Practice Guideline for Diabetes Management in CKD
Mottl, A. K., Alicic, R., Argyropoulos, C., Brosius, F. C., Mauer, M., Molitch, M., Nelson, R. G., Perreault, L. & Nicholas, S. B., Apr 2022, In: American Journal of Kidney Diseases. 79, 4, p. 457-479 23 p.Research output: Contribution to journal › Article › peer-review
Open Access3 Scopus citations